Right Ventricular Function in Obstructive Sleep Apnea
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine the structural and functional cardiac alterations in obstructive sleep apne (OSA) independent from systemic and pulmonary arterial hypertension and their correlation to the severity of OSA.
| Condition |
|---|
|
Sleep Apnea, Obstructive |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | The Evaluation of Subclinical Right Ventricular Dysfunction in Obstructive Sleep Apnea Patients Without Systemic and Pulmonary Arterial Hypertension Using Velocity Vector Imaging |
| Enrollment: | 53 |
| Study Start Date: | June 2006 |
| Study Completion Date: | June 2008 |
| Primary Completion Date: | June 2008 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Newly diagnosed obstructive sleep apnea patients without systemic and pulmonary arterial hypertension
|
|
2
Age, sex and and body mass index-matched matched healthy subjects
|
Detailed Description:
Many risk factors for OSA, such as male gender, obesity, and increasing age are the same as for cardiovascular diseases. This fact makes it more difficult to establish a causal relationship between OSA and cardiovascular diseases. The relationship between OSA and right ventricular (RV) function is controversial. RV dysfunction may be a result of chronic intermittent hypoxia and hypercapnia during apneic episodes. It may also occur secondary to left ventricular dysfunction as a result of increased afterload and sympathetic activity which causes secondary hypertension. As systemic hypertension is one of the most accompanying and contributing factors in OSA along with obesity, we tried to compare the effects of newly diagnosed OSA on RV function with an age and body mass index- matched control group.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Tertiary care clinic, obstructive sleep apnea patients
Inclusion Criteria:
For OSA patients (group1)
- Apnea Hypopnea Index equal or more than 15
- Epworth sleepiness scale equal or more than 10
- No previous treatment for OSA
Exclusion Criteria:
- Age < 18 years
- Known hypertension, or 24-hour mean blood pressure of 135 and/or 85 mmHg or more
- Mean pulmonary artery pressure > 25 mmHg
- Diabetes mellitus
- Left ventricular ejection fraction < 60%
- Moderate to severe valvular disease
- Cardiomyopathy
- Renal failure
- Coronary artery disease
- Obstructive or restrictive lung disease demonstrated on pulmonary function test
- Connective-tissue or chronic thromboembolic disease
- Pericardial disease
- Cancer and/or other important comorbidities with an expected survival < 2 years
- Suboptimal echocardiographic images for measurements
Contacts and Locations| Turkey | |
| Florence Nightingale Hospital | |
| Istanbul, Caglayan, Turkey, 34381 | |
| Principal Investigator: | Saide Aytekin | T.C. Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology |
More Information
Publications:
| Responsible Party: | Prof. Dr. Saide Aytekin, T.C. Istanbul Bilim University; Florence Nightingale Hospital |
| ClinicalTrials.gov Identifier: | NCT00640536 History of Changes |
| Other Study ID Numbers: | AT-1974/1 |
| Study First Received: | March 17, 2008 |
| Last Updated: | November 28, 2008 |
| Health Authority: | Turkey: Ministry of Health Turkey: Ethics Committee |
Additional relevant MeSH terms:
|
Apnea Sleep Apnea Syndromes Ventricular Dysfunction, Right Ventricular Dysfunction Sleep Apnea, Obstructive Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory |
Signs and Symptoms Sleep Disorders, Intrinsic Dyssomnias Sleep Disorders Nervous System Diseases Heart Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 19, 2013